Скачать с ютуб Cutaneous Squamous Cell Carcinoma - Updates in Immunotherapy presented by Dr. Butler MD в хорошем качестве

Cutaneous Squamous Cell Carcinoma - Updates in Immunotherapy presented by Dr. Butler MD

Watch a live recording of our recent webinar with Dr. Marcus Butler, MD on the "Evolving Landscape of Cutaneous Squamous Cell Carcinoma Treatment: Updates on Immunotherapy Treatment" Cutaneous Squamous Cell Carcinoma (cSCC) is the second most common form of skin cancer in Canada, with an estimated 16,000+ patients nationally. It is forecasted that anywhere from 200-700 of these patients have locally advanced or metastatic cSCC. This livestreaming program targets surgeons from a number of specialties that are involved in the treatment of cSCC patients, to advise on a new, recently approved curative treatment. Cemiplimab is a fully-human monoclonal antibody that is the first and only biologic immunotherapy treatment specifically approved and available for adult patients with metastatic or locally advanced cSCC. You Are Not Alone - cSCC patient support https://www.melanomanetwork.ca/csccin... Download a copy of our cSCC patient guide - Helping You Understand cutaneous Squamous Cell Carcinoma (cSCC) A Patient Guide https://www.melanomanetwork.ca/csccin... cSCC Treatment information https://www.melanomanetwork.ca/csccin... About Dr. Marcus Butler Dr. Marcus Butler, MD Medical Oncologist, Princess Margaret Cancer Centre, University Health Networ Melanoma Network of Canada https://www.melanomanetwork.ca/ 1.877.560.8035 [email protected] Facebook   / melanomanetwork   Twitter   / melanomanetwork   Instagram   / melanomanetwork